azacyclonol

This page covers all azacyclonol drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Histamine H1 receptor, Sodium channel alpha subunits; brain (Types I, II, III).

Targets

Histamine H1 receptor, Sodium channel alpha subunits; brain (Types I, II, III)

Phase 2 pipeline (1)

• Calmeran · Other
  Calmeran works by blocking the histamine H1 receptor, which helps to reduce allergic responses and other physiological effects caused by histamine.

Patent intelligence

• azacyclonol patent landscape — aggregated cliff calendar, attackable patents, originator estates